Activation of murine macrophages by Neisseria meningitidis and IFN-gamma in vitro: distinct roles of class A scavenger and Toll-like pattern recognition receptors in selective modulation of surface phenotype

J Leukoc Biol. 2004 Sep;76(3):577-84. doi: 10.1189/jlb.0104014. Epub 2004 Jun 24.

Abstract

Innate and adaptive immune activation of macrophages (Mphi) by microorganisms and antigen-activated lymphoid cells, respectively, plays an important role in host defense and immunopathology. Antigen-presenting cells express a range of pattern recognition receptors including the class A types I and II scavenger receptors (SR-A) and Toll-like receptors (TLR). Recognition of microbial products by SR-A and TLR controls uptake, killing, altered gene expression, and the adaptive immune response; however, the contribution of each receptor and interplay with cytokine stimuli such as interferon-gamma (IFN-gamma) are not defined. We used Neisseria meningitidis (NM), a potent activator of innate immunity, and IFN-gamma, a prototypic T helper cell type 1 proinflammatory cytokine, to compare surface antigens, secretion of mediators, and receptor functions in elicited peritoneal Mphi from wild-type and genetically modified mouse strains. We show that these stimuli regulate major histocompatibility complex type II (MHC-II) and costimulatory molecules differentially, as well as expression of the mannose receptor and of Mphi receptor with collagenous structure (MARCO), a distinct SR-A, which provides a selective marker for innate activation. In combination, NM inhibited up-regulation of MHC-II by IFN-gamma while priming enhanced release of tumor necrosis factor alpha and nitric oxide. The SR-A contributes to phagocytosis of the organisms but not to their ability to induce CD80, CD86, and MARCO or to inhibit MHC-II. Conversely, studies with lipopolysaccharide (LPS)-deficient organisms and/or TLR-4 mutant mice showed that LPS and TLR-4 are at least partially required to induce CD80, CD86, and MARCO, but LPS is not required to inhibit MHC-II. These studies provide an experimental model and identify surface markers for analysis of innate and acquired immune activation of Mphi.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, CD / drug effects
  • Antigens, CD / immunology
  • B7-1 Antigen / drug effects
  • B7-1 Antigen / immunology
  • B7-2 Antigen
  • CD36 Antigens / immunology*
  • Chemotaxis, Leukocyte / drug effects
  • Chemotaxis, Leukocyte / immunology*
  • Histocompatibility Antigens Class II / immunology
  • Immunity, Innate / drug effects
  • Immunity, Innate / immunology*
  • In Vitro Techniques
  • Inflammation Mediators / immunology*
  • Interferon-gamma / immunology
  • Interferon-gamma / pharmacology
  • Lectins, C-Type / immunology
  • Lipopolysaccharides / immunology
  • Lipopolysaccharides / metabolism
  • Macrophages / drug effects
  • Macrophages / immunology*
  • Mannose Receptor
  • Mannose-Binding Lectins / immunology
  • Membrane Glycoproteins / deficiency
  • Membrane Glycoproteins / drug effects
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / immunology*
  • Mice
  • Mice, Knockout
  • Neisseria meningitidis / immunology
  • Phenotype
  • Receptors, Cell Surface / deficiency
  • Receptors, Cell Surface / genetics
  • Receptors, Cell Surface / immunology*
  • Receptors, Immunologic / immunology
  • Scavenger Receptors, Class A
  • Toll-Like Receptor 4
  • Toll-Like Receptors
  • Tumor Necrosis Factor-alpha / immunology
  • Up-Regulation / immunology

Substances

  • Antigens, CD
  • B7-1 Antigen
  • B7-2 Antigen
  • CD36 Antigens
  • Cd86 protein, mouse
  • Histocompatibility Antigens Class II
  • Inflammation Mediators
  • Lectins, C-Type
  • Lipopolysaccharides
  • Mannose Receptor
  • Mannose-Binding Lectins
  • Marco protein, mouse
  • Membrane Glycoproteins
  • Receptors, Cell Surface
  • Receptors, Immunologic
  • Scavenger Receptors, Class A
  • Toll-Like Receptor 4
  • Toll-Like Receptors
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma